Press Releases July 15, 2026 04:05 PM

Teladoc Health to Announce Second Quarter 2026 Financial Results

Teladoc Health schedules Q2 2026 earnings release and conference call for July 29

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
TDOC

Teladoc Health Inc., a leading global virtual care company, announced it will release its second quarter 2026 financial results after market close on July 29, 2026, followed by a conference call at 5:00 p.m. ET to discuss the results. Access details for the call and replay are provided to investors and interested parties.

Teladoc Health to Announce Second Quarter 2026 Financial Results
TDOC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Teladoc Health is set to announce Q2 2026 financial results on July 29, after market close.
  • A conference call will follow at 5:00 p.m. ET for discussion and investor engagement.
  • Teladoc is a global leader in virtual care, working with health plans, employers, and providers to improve healthcare access and outcomes.

NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.

Conference Call Details

The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the meeting ID # 478 236 923.

For international participants, please visit the following link for global dial-in numbers, using the same meeting ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health

Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Investors:
Michael Minchak
[email protected] 
617-444-9612


Risks

  • Potential market volatility or negative reaction depending on earnings results, which are currently unknown.
  • Macro-economic or healthcare sector trends could impact the company's financial performance.
  • Rapid changes in virtual healthcare regulation or technology could affect Teladoc's market position.

More from Press Releases

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026 AiRWA receives expected notification of deficiency from Nasdaq related to delayed filing of annual report on Form 10-K Aug 28, 2026